Table 3.
Unadjusted and adjusted Hazard Ratios (and 95% CI) for decompensation, development of HCC and a composite endpoint of death, decompensation or development of HCC by CD8+CD45RO+ and CD4+CD45RO+ T-lymphocyte telomere length and age in whole viraemic cohort (n = 124) or subjects with severe fibrosis (n = 55).
![]() |
Bold indicates significant results.